Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Anumana logo — Unlocking the Language of the Heart & Transforming Cardiac C...

Anumana

Unlocking the Language of the Heart & Transforming Cardiac Care Through Cutting-Edge AI Solutions

Founded 2021 United States Cambridge, United States 88 employees Series C Total: $117.70M AI, Health Care +1

General Information

Company Name Anumana
Founded Year 2021
Location United States Cambridge, United States
Founders / Decision Makers
Team member
Employees 88
Industries AI, Health Care, Medical Devices
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Anumana. To contact Anumana, visit anumana.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Anumana compare?

A PDF of Anumana and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Anumana soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Anumana

Anumana, founded in 2021 and headquartered in the United States, operates at the intersection of AI, Health Care, and Medical Devices. The company is dedicated to "Unlocking the Language of the Heart & Transforming Cardiac Care Through Cutting-Edge AI Solutions."

Anumana leverages advanced AI and translational science to interpret electrical signals from the heart, potentially revolutionizing patient care in the cardiac clinical pathway. With over 100+ peer-reviewed publications, Anumana shows promise in early detection and diagnosis of hidden heart conditions, propelling the concept of precision medicine.

The company secured a Series C investment on 24 April 2025, backed by prominent investors like Boston Scientific, Matrix Capital Management, Mayo Clinic Ventures, Matrix, and NTT Venture Capital. This financial support underscores confidence in Anumana's potential to set a new standard in cardiac clinical care.

Business keywords: AI Solutions, Cardiac Care, Electrical Signals Analysis, ECG-EGM-EMR Integration, Precision Medicine, Clinical Decision Support, Machine Learning Algorithms, Cardiovascular Disease Diagnosis, Real-world Evidence Generation, Healthcare Analytics, Patient Care Transformation, Diagnostic Technology, Clinical Pathway Enhancement, Data-Driven Healthcare

Services & Products

Development and commercialization of AI solutions for cardiac care continuum

Target Customers

Healthcare institutions clinicians and patients

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series C Undisclosed 5
Boston Scientific Matrix Capital Management Mayo Clinic Ventures
Boston Scientific, Matrix Capital Management +3
24 Apr 2025
Venture Round $32.00M -
17 Nov 2022
Non Equity Assistance Undisclosed 1
MedTech Innovator
MedTech Innovator
07 Jun 2022
Series B $60.00M 5
Mayo Clinic Ventures NTT VC Matrix Capital Management
Mayo Clinic Ventures, NTT VC +3
01 May 2021
Series A $25.70M 4
Mayo Clinic Ventures NTT VC Matrix Capital Management
Mayo Clinic Ventures, NTT VC +2
14 Apr 2021

Anumana Alternatives & Competitors

View All Alternatives
Anumana vs
Quinten Health
Quinten Health France

Trusted AI for precision medicine

Venture round
38 employees
AI, Data Analytics
Compare Anumana vs Quinten Health
Anumana vs
Heartflow
Heartflow United States

Decisive Coronary Care.

IPO
823 employees
AI, Biotechnology
Compare Anumana vs Heartflow
Anumana vs
Cohesic Inc
Cohesic Inc Canada

BETTER CARE THROUGH BETTER DATA

Seed
21 employees
AI, Health Care
Also compare with: Anumana vs Viz.ai Viz.ai View all alternatives

FAQ About Anumana

Unlocking the Language of the Heart & Transforming Cardiac Care Through Cutting-Edge AI Solutions
Anumana was founded in 2021.
Anumana is headquartered in Cambridge, United States.
Anumana operates in AI, Health Care and Medical Devices. Its work centres on AI Solutions, Cardiac Care, Electrical Signals Analysis and ECG-EGM-EMR Integration. Its customers include Healthcare institutions, clinicians and and patients.
Anumana has approximately 88 employees.
Anumana has completed 5 funding rounds, raising a total of $117.70M. The latest funding stage is Series C.
Anumana offers: Development and commercialization of AI solutions for cardiac care continuum.
Top alternatives and competitors to Anumana include Quinten Health , Heartflow, Cohesic Inc, Perceiv, HEALWELL AI (TSX: AIDX). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Anumana and Quinten Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Anumana, https://bouncewatch.com/company/anumana, updated 14 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout